Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
The makers of weight-loss drugs Wegovy and Zepbound are lowering prices significantly, effective immediately, to make them more affordable.
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...
"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
1don MSN
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
10don MSN
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
A study suggests that weight loss medications like Ozempic may help ... Eli Lilly says a new trial showed the key ingredient in its popular drugs Zepbound and Mounjaro helped slash the chance ...
It leaves Ireland particularly exposed to Trump’s trade tariffs. “We have lots of global supply chains that are operating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback